Variant report
Variant | nsv891396 |
---|---|
Chromosome Location | chr8:115698493-115781895 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:115777295..115780044-chr8:115780292..115782239,2 | MCF-7 | breast: | |
2 | chr7:120719872..120722285-chr8:115706379..115707879,2 | K562 | blood: | |
3 | chr8:115690493..115692779-chr8:115729828..115731998,2 | K562 | blood: | |
4 | chr8:115777295..115780044-chr8:115780292..115782239,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7826427 | chr8:115724639-115724640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs567979255 | chr8:115724647-115724648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148052080 | chr8:115724702-115724703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73705369 | chr8:115724744-115724745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7844837 | chr8:115724746-115724747 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs568486405 | chr8:115724768-115724769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192074322 | chr8:115724773-115724774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182717017 | chr8:115724809-115724810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187398092 | chr8:115724923-115724924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377656009 | chr8:115724927-115724928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534019878 | chr8:115724940-115724941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7830645 | chr8:115724941-115724942 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs573895271 | chr8:115724990-115724991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200021471 | chr8:115725021-115725022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73705370 | chr8:115725041-115725042 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs116502663 | chr8:115725045-115725046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573762931 | chr8:115725062-115725063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191528784 | chr8:115725083-115725084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7462721 | chr8:115725090-115725091 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs76073518 | chr8:115725097-115725098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572429267 | chr8:115725114-115725115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543242016 | chr8:115725344-115725345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79139770 | chr8:115725345-115725346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185007576 | chr8:115725347-115725348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs189121383 | chr8:115725381-115725382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192799863 | chr8:115725429-115725430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555908438 | chr8:115725435-115725436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111700264 | chr8:115725479-115725480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562154124 | chr8:115725518-115725519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2357698 | chr8:115725545-115725546 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs138061611 | chr8:115725713-115725714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566594760 | chr8:115725913-115725914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533615531 | chr8:115725970-115725971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549182317 | chr8:115726085-115726086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567301488 | chr8:115726107-115726108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538145119 | chr8:115726127-115726128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185550619 | chr8:115726149-115726150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12546367 | chr8:115726164-115726165 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs539065993 | chr8:115726167-115726168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189286605 | chr8:115726203-115726204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572522063 | chr8:115726214-115726215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542730306 | chr8:115726257-115726258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6988312 | chr8:115726314-115726315 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs7006212 | chr8:115726321-115726322 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs565284611 | chr8:115726329-115726330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532650208 | chr8:115726341-115726342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551370663 | chr8:115726342-115726343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559866679 | chr8:115726371-115726372 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142576477 | chr8:115726374-115726375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs117277348 | chr8:115726404-115726405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:115724600-115725800 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr8:115724800-115725200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr8:115724800-115725600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr8:115725000-115726400 | Enhancers | Hela-S3 | cervix |
5 | chr8:115725600-115729600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr8:115729200-115730200 | Enhancers | Dnd41 | blood |
7 | chr8:115729600-115730200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr8:115730200-115732400 | Weak transcription | Dnd41 | blood |
9 | chr8:115732400-115732600 | Enhancers | Dnd41 | blood |
10 | chr8:115736000-115738200 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
11 | chr8:115740600-115741800 | Enhancers | Dnd41 | blood |
12 | chr8:115758200-115758600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr8:115758600-115758800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr8:115758800-115767200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr8:115761800-115762000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr8:115767200-115767600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr8:115767200-115768000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr8:115767400-115767800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr8:115768600-115769200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
20 | chr8:115778600-115779200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr8:115778800-115779400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr8:115779000-115779800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
23 | chr8:115779200-115779600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
24 | chr8:115779600-115779800 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
25 | chr8:115780000-115780600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
26 | chr8:115781000-115781200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |